A Registry to Evaluate Patterns of Care Associated With the Use of Corus CAD (or ASGES) in Primary Care Settings
Status: | Completed |
---|---|
Conditions: | Angina, Peripheral Vascular Disease, Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/2/2019 |
Start Date: | August 2012 |
End Date: | October 2015 |
The PRESET Registry: A Registry to Evaluate Patterns of Care Associated With the Use of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Real World Clinical Care Settings
The PRESET Registry--A Registry to Evaluate Patterns of Care Associated With the Use of Corus
CAD (Age/Sex/Gene Expression score - ASGES) in Real World Clinical Care Settings
(PRESET)--was designed as an observational, post-market, real-world registry to evaluate
patterns of care, including referrals to a cardiologist, cardiac stress testing, CT
angiography, within the first month after Corus CAD (ASGES) testing.
CAD (Age/Sex/Gene Expression score - ASGES) in Real World Clinical Care Settings
(PRESET)--was designed as an observational, post-market, real-world registry to evaluate
patterns of care, including referrals to a cardiologist, cardiac stress testing, CT
angiography, within the first month after Corus CAD (ASGES) testing.
The prospective PRESET Registry (NCT01677156) enrolled stable, nonacute adult patients
presenting with typical or atypical symptoms suggestive of obstructive coronary artery
disease from 21 US primary care practices from August 2012 to August 2014. Demographics,
clinical characteristics, and Corus CAD (Age/Sex/Gene Expression score - ASGES) results
(predefined as low [ASGES <15] or elevated [ASGES >15]) were collected, as were referrals to
Cardiology or further functional/anatomic cardiac testing after Corus CAD (Age/Sex/Gene
Expression score - ASGES) testing. Patients were followed for 1 year post ASGES testing.
presenting with typical or atypical symptoms suggestive of obstructive coronary artery
disease from 21 US primary care practices from August 2012 to August 2014. Demographics,
clinical characteristics, and Corus CAD (Age/Sex/Gene Expression score - ASGES) results
(predefined as low [ASGES <15] or elevated [ASGES >15]) were collected, as were referrals to
Cardiology or further functional/anatomic cardiac testing after Corus CAD (Age/Sex/Gene
Expression score - ASGES) testing. Patients were followed for 1 year post ASGES testing.
Inclusion Criteria:
1. Symptoms suggestive of CAD, according to the opinion of the site registry clinician
2. Receiving Corus CAD (ASGES) to aid in the diagnosis of obstructive CAD
3. Age >= 18 years
4. Willing and able to provide written informed consent
Exclusion Criteria:
1. History of myocardial infarction (MI)
2. Current MI or acute coronary syndrome
3. Current New York Heart Association (NYHA) class III or IV congestive heart failure
symptoms
4. Known/documented CAD
5. Diabetes Mellitus
We found this trial at
13
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials